Status:

TERMINATED

Zinc and Green Tea Extract for Community Respiratory Viral Infections

Lead Sponsor:

University of Missouri-Columbia

Conditions:

Respiratory Viral Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Zinc and green tea supplementation have both been independently studied for supporting immune health during cold and flu-like illness in non-hospitalized patients with clinical trials demonstrating pr...

Eligibility Criteria

Inclusion

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 18 years and older
  • Ability to take oral medication and be willing to adhere to the prescribed dosing regimen
  • Self-reported cold or flu symptoms for \< 72 hours

Exclusion

  • Pregnant or actively seeking to become pregnant
  • Positive for influenza with planned treatment with oseltamivir or baloxavir
  • Current or planned treatment with an FDA regulated drug (including those under EUA) for COVID-19
  • Chronic liver disease (i.e. baseline liver function tests (LFTs) \> 1.5x the upper limit of normal (ULN) or established cirrhosis
  • Chronic renal failure stage 4 or greater
  • History of kidney stones
  • Acute secondary bacterial infection at the time of enrollment
  • Requiring hospitalization for any reason at the time of enrollment
  • History of copper or iron deficiency
  • Current prescription for quinolone antibiotics, tetracycline antibiotics, or penicillamine at the time of enrollment
  • Allergy/intolerance to any of the active ingredients under investigation including zinc citrate, green tea, and ascorbic acid (vitamin C)
  • Patients without decision making capacity
  • Currently enrolled in another clinical trial for a respiratory viral infection

Key Trial Info

Start Date :

September 21 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2023

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT04898023

Start Date

September 21 2022

End Date

December 20 2023

Last Update

March 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Missouri

Columbia, Missouri, United States, 65212